Watson Pharmaceuticals (WPI): S&P Intraday Gainer

NEW YORK ( TheStreet) -- Watson Pharmaceuticals ( WPI) was the best-performing stock in the S&P 500 Thursday morning.

The S&P was down 9.68 points, or 0.68%, to 1,393.21 early Thursday.

Shares of Watson rose 4.99% to $66.87. The company is reportedly in talks to acquire Swiss generic drug manufacturer Actavis.

Watson was also wasthe top performer in the S&P 500 on Wednesday; it gained 8.82% that day.

Watson has an estimated price-to-earnings ratio of 10.84 times; the average for pharmaceutical companies is 31.84. For comparison, Mylan ( MYL) has a lower forward P/E of 10.84; Perrigo's ( PRGO) forward P/E is 18.78.

Eighteen of the 25 analysts who cover Watson rated it buy; seven analysts gave the stock a hold rating.

TheStreet Ratings gives Watson a B+ grade with a buy rating and a $76.90 price target. The stock has risen 10.67% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

-- Written by Alexandra Zendrian

>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to: tips@thestreet.com.

>To follow the writer on Twitter, go to Alexandra Zendrian.

If you liked this article you might like

Novice Trade: UVXY

Gold Prices Have Just Formed a Classic Technical Pattern That Hints Even Higher Prices Are Coming

7 of 11 S&P Sector ETFs Set Post-Election Highs, While Energy Sets Post-Election Low

The Stock Market Has Been Amazingly Resilient -- Check Out These 10 Charts